Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension

Aim. To study the effect of corenitek monotherapy for 16 weeks on parameters of 24-h monitoring of arterial pressure, carbohydrate, lipid, purin metabolism in patients with mild and moderate arterial hypertension (AH) and diabetes mellitus (DM) type 2. Material and methods. 20 patients with DM type...

Full description

Bibliographic Details
Main Authors: I E Chazova, V В Mychka, D E Duishvili
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2004-08-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/29879
_version_ 1818286961135190016
author I E Chazova
V В Mychka
D E Duishvili
author_facet I E Chazova
V В Mychka
D E Duishvili
author_sort I E Chazova
collection DOAJ
description Aim. To study the effect of corenitek monotherapy for 16 weeks on parameters of 24-h monitoring of arterial pressure, carbohydrate, lipid, purin metabolism in patients with mild and moderate arterial hypertension (AH) and diabetes mellitus (DM) type 2. Material and methods. 20 patients with DM type 2, mild or moderate AH received co-renitek (1-2 tablets a day) for 16 weeks. Before the treatment and 16 weeks later the patients were examined (24h AH monitoring, carbohydrate, lipid, purin, electrolyte metabolism). Results. Co-renitek treatment of DM type 2 patients with hypertension led to a significant lowering of mean systolic and diastolic pressure, improvement of 24-h AP profde and reduction of fasting glucose level. Co-renitek proved to be metabolically neutral in relation to lipid, purin and electrolyte metabolism. Conclusion. Co-renitek is effective and safe antihypertensive drug for treatment of arterial hypertension in patients with diabetes mellitus type 2.
first_indexed 2024-12-13T01:32:54Z
format Article
id doaj.art-76126997dfbf4907a4b8ae02659b6f19
institution Directory Open Access Journal
issn 0040-3660
2309-5342
language Russian
last_indexed 2024-12-13T01:32:54Z
publishDate 2004-08-01
publisher "Consilium Medicum" Publishing house
record_format Article
series Терапевтический архив
spelling doaj.art-76126997dfbf4907a4b8ae02659b6f192022-12-22T00:03:57Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422004-08-01798283126907Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertensionI E ChazovaV В MychkaD E DuishviliAim. To study the effect of corenitek monotherapy for 16 weeks on parameters of 24-h monitoring of arterial pressure, carbohydrate, lipid, purin metabolism in patients with mild and moderate arterial hypertension (AH) and diabetes mellitus (DM) type 2. Material and methods. 20 patients with DM type 2, mild or moderate AH received co-renitek (1-2 tablets a day) for 16 weeks. Before the treatment and 16 weeks later the patients were examined (24h AH monitoring, carbohydrate, lipid, purin, electrolyte metabolism). Results. Co-renitek treatment of DM type 2 patients with hypertension led to a significant lowering of mean systolic and diastolic pressure, improvement of 24-h AP profde and reduction of fasting glucose level. Co-renitek proved to be metabolically neutral in relation to lipid, purin and electrolyte metabolism. Conclusion. Co-renitek is effective and safe antihypertensive drug for treatment of arterial hypertension in patients with diabetes mellitus type 2.https://ter-arkhiv.ru/0040-3660/article/view/29879diabetes mellitus type 2arterial hypertensionanalaprilhydrochlorothiaside24-h monitoring of arterial pressure
spellingShingle I E Chazova
V В Mychka
D E Duishvili
Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension
Терапевтический архив
diabetes mellitus type 2
arterial hypertension
analapril
hydrochlorothiaside
24-h monitoring of arterial pressure
title Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension
title_full Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension
title_fullStr Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension
title_full_unstemmed Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension
title_short Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension
title_sort thiaside diuretics in combination with inhibitors of angiotensin converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension
topic diabetes mellitus type 2
arterial hypertension
analapril
hydrochlorothiaside
24-h monitoring of arterial pressure
url https://ter-arkhiv.ru/0040-3660/article/view/29879
work_keys_str_mv AT iechazova thiasidediureticsincombinationwithinhibitorsofangiotensinconvertingenzymeinpatientswithdiabetesmellitustype2comorbidwitharterialhypertension
AT vvmychka thiasidediureticsincombinationwithinhibitorsofangiotensinconvertingenzymeinpatientswithdiabetesmellitustype2comorbidwitharterialhypertension
AT deduishvili thiasidediureticsincombinationwithinhibitorsofangiotensinconvertingenzymeinpatientswithdiabetesmellitustype2comorbidwitharterialhypertension